Sale!

MDS Panel Cytogenetics FISH del5q del7q del20q

Original price was: $426.Current price is: $318.

-25%

The MDS Panel Cytogenetics FISH del5q del7q del20q test is a comprehensive genetic analysis specifically designed for diagnosing and monitoring Myelodysplastic Syndromes (MDS). This advanced test combines conventional cytogenetics with fluorescence in situ hybridization (FISH) technology to detect critical chromosomal abnormalities including deletions in chromosomes 5q, 7q, and 20q. These specific genetic markers are essential for accurate MDS diagnosis, risk stratification, and treatment planning. The test is particularly valuable for patients presenting with unexplained cytopenias, abnormal blood counts, or suspected bone marrow disorders. With results available in 5-7 days and a discounted price of $318 USD (regularly $426 USD), this test provides crucial information for hematologists and oncologists managing MDS patients. Early detection of these chromosomal abnormalities can significantly impact treatment decisions and patient outcomes.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MDS Panel Cytogenetics FISH del5q del7q del20q Test

Comprehensive Genetic Testing for Myelodysplastic Syndromes

The MDS Panel Cytogenetics FISH del5q del7q del20q represents a cutting-edge diagnostic approach for evaluating patients with suspected or confirmed Myelodysplastic Syndromes (MDS). This sophisticated test combines traditional cytogenetic analysis with advanced fluorescence in situ hybridization (FISH) technology to provide a comprehensive genetic profile essential for accurate diagnosis, prognosis, and treatment planning in MDS patients.

What This Test Measures and Detects

This specialized panel specifically targets three critical chromosomal regions frequently associated with MDS:

  • del(5q) Abnormality: Detects deletions in the long arm of chromosome 5, commonly associated with the “5q- syndrome” – a distinct MDS subtype with specific clinical features and treatment implications
  • del(7q) Abnormality: Identifies deletions in chromosome 7q, which are associated with higher-risk MDS and poorer prognosis
  • del(20q) Abnormality: Screens for deletions in chromosome 20q, another common cytogenetic abnormality in MDS patients

Who Should Consider This Test

This test is recommended for individuals presenting with:

  • Unexplained cytopenias (low blood counts) including anemia, thrombocytopenia, or neutropenia
  • Abnormal peripheral blood smear findings suggestive of MDS
  • Persistent fatigue, weakness, or unexplained bruising/bleeding
  • Recurrent infections due to low white blood cell counts
  • Previous abnormal bone marrow biopsy results
  • Monitoring of known MDS patients for disease progression
  • Evaluation before considering specific MDS treatments like lenalidomide

Key Benefits of MDS Genetic Testing

  • Accurate Diagnosis: Provides definitive genetic evidence for MDS diagnosis
  • Risk Stratification: Helps determine prognosis and disease aggressiveness
  • Treatment Guidance: Informs treatment selection, including targeted therapies
  • Disease Monitoring: Tracks genetic changes over time for treatment response assessment
  • Early Intervention: Enables timely treatment decisions that can improve outcomes

Understanding Your Test Results

Your test results will provide detailed information about the presence or absence of specific chromosomal abnormalities:

  • Normal Results: No detected abnormalities in chromosomes 5q, 7q, or 20q
  • del(5q) Positive: May indicate 5q- syndrome, often associated with better prognosis and specific treatment options
  • del(7q) Positive: Typically associated with higher-risk disease requiring more aggressive treatment
  • del(20q) Positive: Common finding in MDS with variable prognostic significance
  • Complex Abnormalities: Multiple abnormalities may indicate more advanced disease

Your hematologist will interpret these results in the context of your complete clinical picture, including blood counts, bone marrow findings, and overall health status.

Test Pricing Information

Test Name Discount Price Regular Price
MDS Panel Cytogenetics FISH del5q del7q del20q $318 USD $426 USD

Test Specifications

  • Turnaround Time: 5-7 days
  • Sample Type: Bone marrow or Peripheral blood (Transport immediately)
  • Test Components: Sodium Heparin Vacutainer (2ml)
  • Methodology: Cell Culture + FISH (Fluorescence In Situ Hybridization)

Pre-Test Instructions

The MDS Panel (Cytogenetics + FISH [del(5q), del(7q), del(20q)]) requires a Doctor’s prescription. Please note that prescription requirements do not apply for surgery and pregnancy cases or individuals planning to travel abroad.

Nationwide Testing Availability

We have branches across the United States, serving patients in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures convenient access to this essential genetic testing nationwide.

Book Your MDS Genetic Test Today

Take the first step toward comprehensive MDS diagnosis and management. Our experienced genetic counselors and hematology specialists are ready to assist you with this critical testing.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your MDS Panel Cytogenetics FISH del5q del7q del20q test. Early genetic assessment can make a significant difference in your treatment journey and overall outcomes.